Closed-Circuit Breathing Device Xenon Steady-State Control

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current delivery systems for xenon, a potentially therapeutic gas, are expensive, require specialized supervision, and are not optimized for cost-effective use, limiting its clinical application in treating anxiety and addiction disorders.

Innovation Solution

A closed-circuit breathing device that includes a breathing port, sensor assembly, and controller to achieve a steady-state equilibrium of therapeutic gases like xenon, minimizing waste and allowing safe, cost-effective delivery with minimal supervision.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If commercial devices are used to deliver xenon, then xenon can be delivered as an anesthetic agent, but the devices are expensive and require specialized personnel supervision

Engineering Contradiction:
Improvexenon delivery reliabilityVSAvoiddevice complexity and operational requirements
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The system automatically monitors xenon concentration via sensors and adjusts gas delivery without requiring specialized personnel supervision. The controller self-regulates the breathing circuit to maintain therapeutic xenon levels, making the device self-sufficient and eliminating the need for expert operators.

Inventive Principle:
Principle #25Self-service

Solution Approach 2:

The system incorporates sensors that continuously monitor xenon concentration and provide feedback to the controller. This closed-loop feedback mechanism automatically adjusts gas delivery to maintain precise therapeutic levels, replacing the need for manual monitoring by specialized personnel.

Inventive Principle:
Principle #23Feedback

2Reliability

If commercial devices are used to deliver xenon, then xenon delivery is possible, but the devices are not optimized for cost-effective use of the expensive gas

Engineering Contradiction:
Improvexenon delivery capabilityVSAvoidxenon gas waste
Core Design Contradiction:
ReliabilityVSLoss of substance

Solution Approach 1:

Sensors continuously monitor xenon concentration in the breathing circuit and provide feedback to the controller, which precisely regulates gas delivery. This prevents both under-dosing and over-dosing, optimizing xenon utilization and minimizing waste of this expensive therapeutic gas.

Inventive Principle:
Principle #23Feedback

Solution Approach 2:

The system dynamically adjusts xenon concentration parameters based on real-time sensor data and patient needs. By precisely controlling delivery parameters rather than using fixed high-concentration delivery, the system minimizes xenon waste while maintaining therapeutic effectiveness.

Inventive Principle:
Principle #35Parameter changes

3Loss of substance

If a closed-circuit breathing device is used, then steady-state equilibrium can be achieved with minimal gas loss, but the device complexity increases

Engineering Contradiction:
Improvexenon gas lossVSAvoidbreathing circuit complexity
Core Design Contradiction:
Loss of substanceVSDevice complexity

Solution Approach 1:

The system combines multiple functions into integrated components: sensors monitor multiple gas parameters simultaneously, the controller manages both oxygen and xenon delivery, and the breathing circuit handles both gas mixing and patient interface. This integration reduces overall system complexity despite the sophisticated closed-loop control required.

Inventive Principle:
Principle #5Merging (Combining)

Solution Approach 2:

The breathing circuit is designed as a multi-functional system that simultaneously performs gas mixing, concentration monitoring, patient ventilation support, and xenon recovery. This universal design consolidates what would otherwise require separate specialized equipment, managing complexity through functional integration.

Inventive Principle:
Principle #6Universality (Multi-functionality)

4Productivity

If incremental controlled volumes of therapeutic gas are delivered, then steady-state concentration is achieved efficiently, but the control system complexity increases

Engineering Contradiction:
Improvesteady-state achievement speedVSAvoidcontroller complexity
Core Design Contradiction:
ProductivityVSDevice complexity

Solution Approach 1:

The controller delivers therapeutic gas in incremental periodic volumes rather than continuous flow, allowing the system to efficiently reach steady-state concentration. This pulsed delivery approach, combined with periodic sensor monitoring, achieves rapid equilibrium while using relatively simple control logic compared to continuous complex regulation.

Inventive Principle:
Principle #19Periodic action

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The device enables efficient and safe administration of xenon, achieving a steady-state concentration for therapeutic use while minimizing gas loss and operational costs, making it suitable for treating anxiety and addiction disorders.

Implementation Method 1

The sensor assembly is configured to measure at least one of a concentration or a flow rate of gases inhaled out and exhaled into the breathing circuit

Methodology Applied
Scientific EffectGas detection:

Implementation Method 2

The chamber is also in fluid communication with the breathing circuit, and is configured to hold a known volume of a pressurized therapeutic gas

Methodology Applied
Scientific EffectPressure containment: Pressure Increase

Data Source

PatentUS10926053B2Closed-circuit breathing device
Publication Date: 2021.02.23 THE GENERAL HOSPITAL CORP
  • US10926053B2 patent drawing
  • US10926053B2 patent drawing
  • US10926053B2 patent drawing

AI summary

Described here are closed-circuit breathing devices and methods for their use. In general, the closed-circuit breathing device is configured to achieve a steady-state equilibrium, whereby therapeutic gas is introduced into the breathing circuit in small, controlled volumes until a steady state concentration of the therapeutic gas is reached. During this time, the closed-circuit breathing device is operated in a true closed circuit, such that the therapeutic gas is not lost to the atmosphere. Safety measures are built into the closed-circuit breathing device so that a hypoxic mixture is not delivered to the subject. The therapeutic gas may be xenon.